However, its important to find a balance because too high a dose can cause unwanted side effects, while too low of a dose may not provide the desired results
scored positive top-line results in Transcend-T2D-1, a phase III trial evaluating the efficacy and safety of retatrutide, an investigational first-in-class GIP, GLP-1 and glucagon triple hormone receptor agonist, as an adjunct to diet and exercise in type 2 diabetes (T2D)
Leveraging our expertise in the food industry, we provide insights into the GLP-1 market and consumer spending trends, offering guidance, especially for F&B brands and retailers, on how to navigate this evolving landscape
Other viral trends may encourage unregulated supplements or herbal injections, often sold through questionable websites or social media DMs
& Kawashti, A